WO2000011215A3 - Method for diagnostic screening - Google Patents

Method for diagnostic screening Download PDF

Info

Publication number
WO2000011215A3
WO2000011215A3 PCT/US1999/018105 US9918105W WO0011215A3 WO 2000011215 A3 WO2000011215 A3 WO 2000011215A3 US 9918105 W US9918105 W US 9918105W WO 0011215 A3 WO0011215 A3 WO 0011215A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnostic screening
disease
screening
diagnostic
predisposition
Prior art date
Application number
PCT/US1999/018105
Other languages
French (fr)
Other versions
WO2000011215A2 (en
Inventor
Stanley N Lapidus
Original Assignee
Exact Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exact Lab Inc filed Critical Exact Lab Inc
Priority to AU17040/00A priority Critical patent/AU1704000A/en
Publication of WO2000011215A2 publication Critical patent/WO2000011215A2/en
Publication of WO2000011215A3 publication Critical patent/WO2000011215A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism

Abstract

Methods are presented for mass screening of patient populations for indicia of disease, infection, or predisposition to disease.
PCT/US1999/018105 1998-08-14 1999-08-10 Method for diagnostic screening WO2000011215A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU17040/00A AU1704000A (en) 1998-08-14 1999-08-10 Method for diagnostic screening

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9663298P 1998-08-14 1998-08-14
US60/096,632 1998-08-14
US33233199A 1999-06-14 1999-06-14
US09/332,331 1999-06-14

Publications (2)

Publication Number Publication Date
WO2000011215A2 WO2000011215A2 (en) 2000-03-02
WO2000011215A3 true WO2000011215A3 (en) 2000-06-29

Family

ID=26791900

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/018105 WO2000011215A2 (en) 1998-08-14 1999-08-10 Method for diagnostic screening

Country Status (2)

Country Link
AU (1) AU1704000A (en)
WO (1) WO2000011215A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009455A1 (en) * 1989-02-13 1990-08-23 Geneco Pty Ltd Detection of a nucleic acid sequence or a change therein
WO1994023055A1 (en) * 1993-03-30 1994-10-13 United States Biochemical Corporation Cycle sequencing with non-thermostable dna polymerases
US5627032A (en) * 1990-12-24 1997-05-06 Ulanovsky; Levy Composite primers for nucleic acids
WO1997023651A1 (en) * 1995-12-22 1997-07-03 Exact Laboratories, Inc. Methods for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5710028A (en) * 1992-07-02 1998-01-20 Eyal; Nurit Method of quick screening and identification of specific DNA sequences by single nucleotide primer extension and kits therefor
WO1998012354A1 (en) * 1996-09-19 1998-03-26 Affymetrix, Inc. Identification of molecular sequence signatures and methods involving the same
WO1998058084A1 (en) * 1997-06-16 1998-12-23 Exact Laboratories, Inc. High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009455A1 (en) * 1989-02-13 1990-08-23 Geneco Pty Ltd Detection of a nucleic acid sequence or a change therein
US5627032A (en) * 1990-12-24 1997-05-06 Ulanovsky; Levy Composite primers for nucleic acids
US5710028A (en) * 1992-07-02 1998-01-20 Eyal; Nurit Method of quick screening and identification of specific DNA sequences by single nucleotide primer extension and kits therefor
WO1994023055A1 (en) * 1993-03-30 1994-10-13 United States Biochemical Corporation Cycle sequencing with non-thermostable dna polymerases
WO1997023651A1 (en) * 1995-12-22 1997-07-03 Exact Laboratories, Inc. Methods for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
WO1998012354A1 (en) * 1996-09-19 1998-03-26 Affymetrix, Inc. Identification of molecular sequence signatures and methods involving the same
WO1998058084A1 (en) * 1997-06-16 1998-12-23 Exact Laboratories, Inc. High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BESKIN A D ET AL: "ON THE MECHANISM OF THE MODULAR PRIMER EFFECT", NUCLEIC ACIDS RESEARCH, vol. 23, no. 15, 1 January 1995 (1995-01-01), pages 2881 - 2885, XP002054940, ISSN: 0305-1048 *
KRYSAN ET AL.: "IDENTIFICATION OF TRANSFERRED DNA INSERTIONS WITHIN ARABIDOPSIS GENES INVOLVED IN SIGNAL TRANSDUCTION AND ION TRANSPORT", PNAS, vol. 93, 1996, pages 8145 - 8150, XP002117146 *
MCKINNEY ET AL: "Sequence-based identification of T-RNA insertion mutations in Arabidopsis: actin mutants act2-1 and act4-1", PLANT BIOLOGY,US,NEW YORK, NY, vol. 8, no. 4, 1995, pages 613 - 622, XP002117147 *
OROU ET AL.: "ALLELE-SPECIFIC COMPETITIVE BLOCKER PCR: A ONE-STEP METHOD WITH APPLICABILITY TO POOL SCREENING", HUMAN MUTATION, vol. 6, 1995, pages 163 - 169, XP000891995 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence

Also Published As

Publication number Publication date
WO2000011215A2 (en) 2000-03-02
AU1704000A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
EA200000814A1 (en) PHARMACEUTICAL COMPOSITION TOPIRAMAT
UA86582C2 (en) Method for treatment of huntington's chorea with eicosapentaenoic acid
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
AU3397900A (en) System and method for collecting platelets and other blood components
AU2001247311A1 (en) A system and method for obtaining, processing and evaluating patient information for diagnosing disease and selecting treatment
AU5209599A (en) System and method for optimizing medical diagnosis, procedures and claims using a structured search space
AU2001263078A1 (en) Networked medical information system for clinical practices
AU6416198A (en) Diagnostic means useful for predictive assessment of human hepatocellular carc inoma disease (hcc), as well as diagnostic methods using the same
AU5851590A (en) Glucose free primary anticoagulant for blood
EP0771788A3 (en) Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them
WO2000018954A3 (en) Use of pex in the treatment of metabolic bone diseases
AU2002309750A1 (en) Screening, diagnostic and therapeutic methods relating to riz
EP1163515A4 (en) Therapeutic and diagnostic tools for impaired glucose tolerance conditions
MXPA01011182A (en) Methods, compositions and kits for biological indicator of sterilization.
ID23150A (en) ANTITUMOR ACTIVITY STRENGTHENING METHODS OF FATH MEDICINE, COMPOSITION WHICH CONTAINS GUBAL ABAT, ACTIVITIES OF ANTITUMOR ACTIVITIES, UTK METHOD FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN COMPOSITION CONTAINING GUBAL ABAT FOR ANTITUMOR ACTIVITY STRENGTHENING, METHODS FOR EVALUATION OF PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANALYSIS OF ANTITUMOR ACTIVITIES, METHODS OF UTK TO EVALUATE THE PREGNANCY OF DRUG TREATMENT, DN METHOD CONTAINS ANALYSIS OF ANTITUMOR ACTIVITIES, THE METHOD OF UTK TO EVALUATE THE PREGNANCY OF DOCUMENTAL MEDICATION
AU2002327575A1 (en) System and method for screening patients for diabetic retinopathy
WO2001062784A3 (en) Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
HK1055390A1 (en) Isolated stromal cells and methods of using the same
WO2000011215A3 (en) Method for diagnostic screening
AU5539798A (en) Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
DE3770000D1 (en) MACROLIDE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE.
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU2001212603A1 (en) Method for management of blood glucose levels
AU2437501A (en) Constant speed blood sample collection system
AU6509698A (en) Methods for clinical diagnosis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 17040

Kind code of ref document: A

Format of ref document f/p: F

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

122 Ep: pct application non-entry in european phase